Cibc Bancorp Usa Inc. Dynavax Technologies Corp Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 17,502 shares of DVAX stock, worth $195,322. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,502Holding current value
$195,322% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
120MCall Options Held
313KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$244 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$199 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$90.4 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$70.1 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$48.1 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.41B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...